North America TB Diagnostic Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends
Top Countries — Revenue
Access the full forecast model.
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
North America TB Diagnostic Market Analysis — Presence
Geographical Analysis
Click countries to exploreCountry Analysis
North America TB Diagnostic Market Analysis 2026
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| North America TB Diagnostic Total | xxxx | xxxx | xxxx | 4.2% |
| United States | xxxx | xxxx | xxxx | 4% |
| Canada | xxxx | xxxx | xxxx | 5% |
| Mexico | xxxx | xxxx | xxxx | 4.7% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Segmentation Analysis
Test Type breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.
To learn more about market share and segmentation, request the free sample pages.
Competitor Analysis
Competitive Landscape of the TB Diagnostic Market
A wide variety of businesses and organizations involved in creating and offering diagnostic solutions define the competitive landscape of the TB diagnostic market. Many businesses are focusing on developing nations like Africa, Southeast Asia, and India that have high rates of tuberculosis. This includes initiatives to offer accessible and reasonably priced diagnostic options in environments with limited resources. Furthermore, businesses must navigate intricate regulatory frameworks to obtain approval for novel diagnostic products. Adherence to both global and regional norms is essential for both entering and growing markets.
February 2023: To improve laboratory capacities in nations heavily impacted by the HIV and tuberculosis (TB) epidemics, Roche stated that it will be expanding its partnership with the U.S. Centers for Disease Control and Prevention (CDC). In a few chosen nations in Africa, Eastern Europe, Central Asia, and the Western Hemisphere (such as Latin America, Central America, and the Caribbean), Roche and the CDC will work to enhance HIV and tuberculosis prevention, detection, and treatment outcomes through the implementation of a public-private partnership (PPP) called "Lab Networks for Health”. (Source: https://diagnostics.roche.com/us/en/news-listing/2023/roche-joins-cdc-strengthen-labs-fight-against-hiv-tuberculosis.html) April 2024: Revvity, Inc. declared the availability of Allsheng's Auto-Pure 2400 liquid handler for the T-SPOT.TB test. The Auto-Pure 2400 platform offers efficient lab procedures and is simple to use. The T-SPOT.TB test's accuracy and the Auto-Pure 2400 system's efficiency come together to create a potent solution that benefits labs, physicians, and patients in the end. (Source: https://news.revvity.com/press-announcements/press-releases/press-release-details/2024/Revvity-Unveils-a-New-Era-of-Automated-Tuberculosis-Testing/default.aspx)| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Company 1 | ••• | ••• | ••• | ••• |
| Company 2 | ••• | ••• | ••• | ••• |
| Company 3 | ••• | ••• | ••• | ••• |
| Company 4 | ••• | ••• | ••• | ••• |
| Company 5 | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →Report Scope & Analysis
According to Cognitive Market Research, the global TB Diagnostic market size was estimated at USD 2251.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 900.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
- According to Cognitive Market Research, the US had a major share in the TB Diagnostic market with a market size of USD 710.60 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The nation's presence of major players.
- The Canada TB Diagnostic market had a market share of USD 108.08 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's increasing investment.
- The Mexico TB Diagnostic market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 81.96 million in 2024.
Analyst Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The North America TB Diagnostic Market Analysis is witnessing significant growth in the near future.
In 2023, the Nucleic Acid Testing segment accounted for a notable share of the North America TB Diagnostic Market Analysis.
Supriya is a Team Lead at Cognitive Market Research & Consulting, leading research initiatives and strategic intelligence projects across the Healthcare, Pharmaceuticals, and Medical Devices & Consumables sectors. With more than two years of experience in market research and data analysis, she plays a key role in helping organizations navigate complex healthcare ecosystems, identify emerging opportunities, and make informed business decisions through data-driven insights and market intelligence.
Combining expertise in both primary and secondary research methodologies with a strong academic foundation in Marketing and Finance, Supriya oversees the execution of market assessments, competitive intelligence studies, forecasting models, stakeholder interviews, trend analysis, and custom consulting engagements. She collaborates with healthcare providers, pharmaceutical manufacturers, medical device companies, industry experts, and other key stakeholders to gather firsthand market perspectives while validating findings through extensive research. Her ability to interpret clinical, commercial, and market data enables clients to better understand industry developments, regulatory influences, innovation trends, and competitive dynamics.
In her leadership role, she manages end-to-end research projects and guides cross-functional teams in delivering high-quality market reports, consulting solutions, and strategic studies. Her expertise in market estimation, forecasting, and analytical modeling helps organizations evaluate market potential, assess growth opportunities, strengthen competitive positioning, and support strategic planning initiatives. By transforming complex healthcare and life sciences data into actionable business intelligence, she enables clients to make confident decisions in rapidly evolving market environments.
Driven by a passion for healthcare innovation and continuous professional development, Supriya remains committed to staying ahead of industry trends, technological advancements, and changing market conditions. Her leadership, analytical mindset, and dedication to research excellence help organizations mitigate risks, capitalize on emerging opportunities, and achieve sustainable growth across the global healthcare and life sciences landscape.
Frequently Asked Questions
★ Reviews
Rate this report
North America TB Diagnostic Market Analysis — Table of Contents
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
| Test Type | Nucleic Acid Testing, Detection of Drug Resistance (DST), Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method, Other Methods |
|---|---|
| End Use | Diagnostic Laboratories, Hospitals & Clinics, Others |
| List of Competitors | Danaher Corporation, Molbio Diagnostics Pvt. Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Hologic Inc., F. Hoffmann-La Roche Ltd., Qiagen NV., Becton Dickinson & Company |
Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))
- 1.1 Top Competitors Analysis
- 1.1.1 Top Players Ranking 2024
- 1.1.2 New Product Launch Analysis
- 1.2 Company Profile (Data Subject to Availability) Sample Format
- 1.2.1 Danaher Corporation
- 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.1.2 Business Overview
- 1.2.1.3 R&D Investment (Subject to data availability)
- 1.2.1.4 Financials (Subject to data availability)
- 1.2.1.5 Product Types Specification
- 1.2.1.6 Business Strategy
- 1.2.1.7 Recent Developments
- 1.2.1.8 Management Change
- 1.2.1.9 S.W.O.T Analysis
- 1.2.2 Molbio Diagnostics Pvt. Ltd.
- 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.2.2 Business Overview
- 1.2.2.3 R&D Investment (Subject to data availability)
- 1.2.2.4 Financials (Subject to data availability)
- 1.2.2.5 Product Types Specification
- 1.2.2.6 Business Strategy
- 1.2.2.7 Recent Developments
- 1.2.2.8 Management Change
- 1.2.2.9 S.W.O.T Analysis
- 1.2.3 Abbott Laboratories
- 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.3.2 Business Overview
- 1.2.3.3 R&D Investment (Subject to data availability)
- 1.2.3.4 Financials (Subject to data availability)
- 1.2.3.5 Product Types Specification
- 1.2.3.6 Business Strategy
- 1.2.3.7 Recent Developments
- 1.2.3.8 Management Change
- 1.2.3.9 S.W.O.T Analysis
- 1.2.4 Thermo Fisher Scientific Inc.
- 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.4.2 Business Overview
- 1.2.4.3 R&D Investment (Subject to data availability)
- 1.2.4.4 Financials (Subject to data availability)
- 1.2.4.5 Product Types Specification
- 1.2.4.6 Business Strategy
- 1.2.4.7 Recent Developments
- 1.2.4.8 Management Change
- 1.2.4.9 S.W.O.T Analysis
- 1.2.5 Bio-Rad Laboratories
- 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.5.2 Business Overview
- 1.2.5.3 R&D Investment (Subject to data availability)
- 1.2.5.4 Financials (Subject to data availability)
- 1.2.5.5 Product Types Specification
- 1.2.5.6 Business Strategy
- 1.2.5.7 Recent Developments
- 1.2.5.8 Management Change
- 1.2.5.9 S.W.O.T Analysis
- 1.2.6 Inc.
- 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.6.2 Business Overview
- 1.2.6.3 R&D Investment (Subject to data availability)
- 1.2.6.4 Financials (Subject to data availability)
- 1.2.6.5 Product Types Specification
- 1.2.6.6 Business Strategy
- 1.2.6.7 Recent Developments
- 1.2.6.8 Management Change
- 1.2.6.9 S.W.O.T Analysis
- 1.2.7 bioMerieux SA
- 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.7.2 Business Overview
- 1.2.7.3 R&D Investment (Subject to data availability)
- 1.2.7.4 Financials (Subject to data availability)
- 1.2.7.5 Product Types Specification
- 1.2.7.6 Business Strategy
- 1.2.7.7 Recent Developments
- 1.2.7.8 Management Change
- 1.2.7.9 S.W.O.T Analysis
- 1.2.8 Hologic Inc.
- 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.8.2 Business Overview
- 1.2.8.3 R&D Investment (Subject to data availability)
- 1.2.8.4 Financials (Subject to data availability)
- 1.2.8.5 Product Types Specification
- 1.2.8.6 Business Strategy
- 1.2.8.7 Recent Developments
- 1.2.8.8 Management Change
- 1.2.8.9 S.W.O.T Analysis
- 1.2.9 F. Hoffmann-La Roche Ltd.
- 1.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.9.2 Business Overview
- 1.2.9.3 R&D Investment (Subject to data availability)
- 1.2.9.4 Financials (Subject to data availability)
- 1.2.9.5 Product Types Specification
- 1.2.9.6 Business Strategy
- 1.2.9.7 Recent Developments
- 1.2.9.8 Management Change
- 1.2.9.9 S.W.O.T Analysis
- 1.2.10 Qiagen NV.
- 1.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.10.2 Business Overview
- 1.2.10.3 R&D Investment (Subject to data availability)
- 1.2.10.4 Financials (Subject to data availability)
- 1.2.10.5 Product Types Specification
- 1.2.10.6 Business Strategy
- 1.2.10.7 Recent Developments
- 1.2.10.8 Management Change
- 1.2.10.9 S.W.O.T Analysis
- 1.2.11 Becton Dickinson & Company
- 1.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
- 1.2.11.2 Business Overview
- 1.2.11.3 R&D Investment (Subject to data availability)
- 1.2.11.4 Financials (Subject to data availability)
- 1.2.11.5 Product Types Specification
- 1.2.11.6 Business Strategy
- 1.2.11.7 Recent Developments
- 1.2.11.8 Management Change
- 1.2.11.9 S.W.O.T Analysis
- 1.2.1 Danaher Corporation
- 1.1 Top Competitors Analysis
Chapter 2. Global TB Diagnostic Market Analysis
- 2.1 Global TB Diagnostic Market Analysis
- 2.2 Global TB Diagnostic Market Analysis by Test Type
- 2.3 Global TB Diagnostic Market Analysis by End Use
Chapter 3. North America TB Diagnostic Market Analysis
- 3.1 North America TB Diagnostic Market Analysis
- 3.2 North America TB Diagnostic Market Analysis by Country
- 3.3 North America TB Diagnostic Market Analysis by Test Type
- 3.4 North America TB Diagnostic Market Analysis by End Use
- 3.5 North America TB Diagnostic Market Analysis by Key Players
Chapter 4. United States TB Diagnostic Market Analysis
- 4.1 United States TB Diagnostic Market Analysis
- 4.2 United States TB Diagnostic Market Analysis by Test Type
- 4.3 United States TB Diagnostic Market Analysis by End Use
- 4.4 United States TB Diagnostic Market Analysis by Key Players
Chapter 5. Canada TB Diagnostic Market Analysis
- 5.1 Canada TB Diagnostic Market Analysis
- 5.2 Canada TB Diagnostic Market Analysis by Test Type
- 5.3 Canada TB Diagnostic Market Analysis by End Use
- 5.4 Canada TB Diagnostic Market Analysis by Key Players
Chapter 6. Mexico TB Diagnostic Market Analysis
- 6.1 Mexico TB Diagnostic Market Analysis
- 6.2 Mexico TB Diagnostic Market Analysis by Test Type
- 6.3 Mexico TB Diagnostic Market Analysis by End Use
- 6.4 Mexico TB Diagnostic Market Analysis by Key Players
Chapter 7. Test Type Analysis
- 7.1 Nucleic Acid Testing
- 7.2 Detection of Drug Resistance (DST)
- 7.3 Phage Assay
- 7.4 Cytokine Detection Assay
- 7.5 Diagnostic Laboratory Methods
- 7.6 Radiographic Method
- 7.7 Other Methods
Chapter 8. End Use Analysis
- 8.1 Diagnostic Laboratories
- 8.2 Hospitals & Clinics
- 8.3 Others
Chapter 9. Qualitative Analysis (Subject to Data Availability)
- 9.1 Market Drivers
- 9.2 Market Restraints
- 9.3 Market Trends
- 9.4 Market Opportunity
- 9.5 Technological Road Map (Subject to Data Availability)
- 9.6 Product Life Cycle (Subject to Data Availability)
- 9.7 Customer and Buyer Behavior Analysis
- 9.7.1 Digital Engagement, Customer Experience & Relationship Analysis
- 9.7.2 Customer Buying Behavior & Purchase Decision Analysis
- 9.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
- 9.7.4 Pricing, Affordability & Value Perception Analysis
- 9.7.5 Customer Segmentation & Demand Pattern Analysis
- 9.8 Industrial Chain Analysis (Subject to Data Availability)
- 9.8.1 Industry Chain Analysis
- 9.8.2 Manufacturing Cost Analysis
- 9.8.3 Supply Side Analysis
- 9.8.3.1 Raw Material Analysis
- 9.8.3.2 Raw Material Procurement Analysis
- 9.8.3.3 Raw Material Price Trend Analysis
- 9.9 PESTEL Analysis
- 9.9.1 Environmental Factors
- 9.9.2 Legal Factors
- 9.9.3 Technological Factors
- 9.9.4 Economic Factors
- 9.9.5 Political Factors
- 9.9.6 Social Factors
- 9.10 Porter’s Five Forces Analysis
- 9.10.1 Degree of Competition
- 9.10.2 Threat of Substitutes
- 9.10.3 Threat of New Entrants
- 9.10.4 Bargaining Power of Buyers
- 9.10.5 Bargaining Power of Suppliers
- 9.11 Patent Analysis (Subject to Data Availability)
- 9.12 ESG Analysis
- 9.13 Geopolitical Outlook
- 9.13.1 Global Power Realignment & Strategic Alliances
- 9.13.2 Geopolitical Risk Landscape & Conflict Hotspots
- 9.13.3 International Trade Relations & Market Access Environment
- 9.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
- 9.13.5 Supply Chain Resilience, Localization & Resource Nationalism
- 9.13.6 Technology Sovereignty & Digital Geopolitics
- 9.13.7 Strategic Implications for Investment, Growth & Market Entry
- 9.14 AI & Market Transformation
- 9.14.1 Competitive Landscape Disruption & Strategic Shifts
- 9.14.2 AI-Driven Transformation of Industry Value Chain
- 9.14.3 Evolution of Business Models & Revenue Streams
- 9.14.4 AI-Driven Product, Service & Innovation Transformation
- 9.14.5 Customer Behavior, AI Adoption & Future Market Evolution
Chapter 10. Research Findings
- 10.1 Key Takeaways
- 10.2 Analyst Point of View
- 10.3 Assumptions and Acronyms
Chapter 11. Research Methodology and Sources
- 11.1 Primary Data Collection
- 11.1.1 Steps for Primary Data Collection
- 11.1.1.1 Identification of KOL
- 11.1.2 Backward Integration
- 11.1.3 Forward Integration
- 11.1.4 How Primary Research Help Us
- 11.1.5 Modes of Primary Research
- 11.1.1 Steps for Primary Data Collection
- 11.2 Secondary Research
- 11.2.1 How Secondary Research Help Us
- 11.2.2 Sources of Secondary Research
- 11.3 Data Validation
- 11.3.1 Data Triangulation
- 11.4 Data Representation
- 11.1 Primary Data Collection
Athenaeum AI Dashboard
Our Proprietary Methodology
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the North America TB Diagnostic Market Analysis Market analysis.
Primary Intelligence Gathering
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Secondary Data Triangulation
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Expert Validation Protocol
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Athenaeum AI Processing
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Editorial & QA Review
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
Data Assurance Metrics
Analytical Coverage
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
Sources from the Medical Devices and Consumables Industry
The Three Pillars of End-to-End Market Research Services
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the North America TB Diagnostic Market Analysis market.
Market Survey
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the north america tb diagnostic market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
- Buyer intent & sentiment analysis
- Purchase cycle mapping
- Price sensitivity research
- Channel preference profiling
- Competitive perception study
Customized Market Data & Reports
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
- Ready syndicate report
- Custom data scope & segmentation
- Excel quantitative models
- Board-ready PPT with key findings
- Secure cloud portal access
Strategic Consultation
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
- Dedicated analyst assigned to you
- Live walkthrough of findings
- Strategic Q&A sessions
- Go-to-market recommendations
- NDA-protected engagement
Customize This Report
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
